查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572044

主动脉瓣狭窄市场：按瓣膜类型、手术类型、最终用户划分 - 2025-2030 年全球预测

Aortic Stenosis Market by Valve Type (Mechanical Valves, Tissue Valves), Surgery Type (Minimally Invasive Surgery, Open Heart Surgery), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

主动脉瓣狭窄市场2023年估值为82.3亿美元，预计到2024年将达到89.9亿美元，复合年增长率为9.63%，预计到2030年将达到156.7亿美元。

主动脉瓣狭窄（AS）是一种心血管疾病，其特征是主动脉瓣开口变窄，限制了血液从心臟流向身体其他部位。主动脉瓣狭窄市场主要是由人口老化所推动的，老年人更容易患这种疾病，因此需要在诊断和治疗解决方案方面取得进展。市场解决方案的应用涵盖多个领域，包括经导管主动脉瓣置换术(TAVR) 和外科手术，最终用途包括专科医院和心臟护理中心。关键的成长要素包括医疗设备的技术进步、意识和诊断率的提高以及熟练医疗保健专业人员数量的增加。最近的监管核准趋势和正在进行的临床试验也带来了巨大的潜在机会，突显了开发微创治疗方法和改善病患监测系统等关键领域。公司可以透过投资研发以及与医疗保健提供者和技术公司合作来利用这些优势。然而，该市场面临治疗方案成本高昂、监管要求严格以及新兴地区进入有限等限制。创新已经成熟，可以开发具有更高耐用性和性能的下一代阀门系统，以及有助于优化患者追踪和治疗的数位健康解决方案。阀门材料的生物工程研究和成像技术的改进以实现更好的诊断可以提供重要的业务成长途径。市场竞争激烈，各大公司都专注于併购和投资组合多元化以维持市场占有率。地理扩张和新兴市场开拓的策略联盟也可能有效。不断适应不断变化的医疗保健法规并解决价格敏感性问题可以进一步增强市场占有率和成长的可持续性。

主要市场统计
基准年[2023] 82.3亿美元
预测年份 [2024] 89.9亿美元
预测年份 [2030] 156.7亿美元
复合年增长率（%） 9.63%

市场动态：快速发展的主动脉瓣狭窄市场的关键市场洞察

主动脉瓣狭窄市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 政府和私营部门努力改善医疗基础设施和可近性
    • 增加创新治疗方法和设备研发的投资
    • 主动脉瓣狭窄治疗的优惠报销政策和保险范围
    • 医疗费用增加和病人接受手术的意愿增加
  • 市场限制因素
    • 治疗费用上涨
  • 市场机会
    • 微创治疗的出现及其对主动脉瓣狭窄市场的潜在影响
    • 人工智慧在提高主动脉瓣狭窄诊断准确性和治疗效果方面的作用
    • 创新的病人参与策略可增强主动脉瓣狭窄部分的照护和依从性
  • 市场挑战
    • 严格的监管核准

波特五力：主动脉瓣狭窄市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解主动脉瓣狭窄市场的外部影响

外部宏观环境因素在塑造主动脉瓣狭窄市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解主动脉瓣狭窄市场的竞争格局

主动脉瓣狭窄市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵主动脉瓣狭窄市场供应商的绩效评估

FPNV 定位矩阵是评估主动脉瓣狭窄市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製主动脉瓣狭窄市场的成功之路

主动脉瓣狭窄市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 政府和私营部门努力改善医疗基础设施和可近性
      • 增加创新治疗方法和设备研发的投资
      • 主动脉瓣狭窄治疗的优惠报销政策和保险范围
      • 医疗费用增加和病人接受手术介入的意愿增加
    • 抑制因素
      • 治疗费用高
    • 机会
      • 新的微创治疗方法及其对主动脉瓣狭窄市场的潜在影响
      • 人工智慧在提高主动脉瓣狭窄诊断准确性和治疗效果方面的作用
      • 创新的病人参与策略，以增强主动脉瓣狭窄部分的照护和依从性
    • 任务
      • 严格的监管核准
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章主动脉瓣狭窄市场（依瓣膜类型）

  • 机械阀
  • 组织瓣膜

第七章依手术类型分類的主动脉瓣狭窄市场

  • 微创手术
    • 机器人辅助手术
    • 胸腔镜手术
  • 心臟直视手术
    • 全胸骨切开术
    • 部分胸骨切开术

第八章主动脉瓣狭窄市场：依最终用户分类

  • 门诊手术中心
  • 心臟中心
  • 医院
  • 专科诊所

第九章北美及南美主动脉瓣狭窄市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太主动脉瓣狭窄市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲主动脉瓣狭窄市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-535C629188E8

The Aortic Stenosis Market was valued at USD 8.23 billion in 2023, expected to reach USD 8.99 billion in 2024, and is projected to grow at a CAGR of 9.63%, to USD 15.67 billion by 2030.

Aortic stenosis (AS) is a cardiovascular condition characterized by the narrowing of the aortic valve opening, restricting blood flow from the heart to the rest of the body. The market for aortic stenosis is primarily driven by the aging population, as older adults are more susceptible to this condition, thus necessitating advancements in diagnostic and treatment solutions. The application of market solutions spans several areas, including transcatheter aortic valve replacement (TAVR) and surgical procedures, with end-use settings including specialty hospitals and cardiac care centers. Key growth factors include technological advancements in medical devices, increasing awareness and diagnosis rates, and a growing pool of skilled healthcare professionals. Recent regulatory approvals and ongoing clinical trials also present significant potential opportunities, highlighting key areas such as developing minimally invasive therapies and improved patient monitoring systems. Companies can capitalize on these by investing in R&D and partnerships with healthcare providers and technology firms. However, the market faces limitations such as high costs of treatment options, stringent regulatory requirements, and limited accessibility in developing regions. Innovations are ripe in the development of next-generation valve systems that offer enhanced durability and performance, as well as digital health solutions that can assist in patient tracking and treatment optimization. Research in bioengineering for valve materials and improved imaging technologies for better diagnosis can offer substantial business growth avenues. The market is competitive, with major players focusing on mergers and acquisitions and portfolio diversification to maintain market share. Strategic collaborations for geographical expansion and tapping into emerging markets can also be effective. Continuous adaptation to evolving healthcare regulations and addressing price sensitivity can further enhance market presence and growth sustainability.

KEY MARKET STATISTICS
Base Year [2023] USD 8.23 billion
Estimated Year [2024] USD 8.99 billion
Forecast Year [2030] USD 15.67 billion
CAGR (%) 9.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aortic Stenosis Market

The Aortic Stenosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government and private sector initiatives to improve healthcare infrastructure and accessibility
    • Growing investments in research and development for innovative aortic stenosis treatments and devices
    • Favorable reimbursement policies and insurance coverage for aortic stenosis treatments
    • Increasing healthcare expenditure and patient willingness to undergo surgical interventions
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Emerging minimally invasive treatments and their potential impact on the aortic stenosis market
    • The role of artificial intelligence in advancing diagnostic precision and treatment outcomes for aortic stenosis
    • Innovative patient engagement strategies to enhance care and compliance in the aortic stenosis segment
  • Market Challenges
    • Stringent regulatory approvals

Porter's Five Forces: A Strategic Tool for Navigating the Aortic Stenosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aortic Stenosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aortic Stenosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aortic Stenosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aortic Stenosis Market

A detailed market share analysis in the Aortic Stenosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aortic Stenosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aortic Stenosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aortic Stenosis Market

A strategic analysis of the Aortic Stenosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aortic Stenosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Balton Sp. z o.o., Biomerics, Boston Scientific, Bracco Diagnostics, Braile Biomedica, Cardiovalve, Claret Medical, CryoLife, Edwards Lifesciences, JenaValve Technology, Johnson & Johnson, LivaNova, Medtronic, Meril Life Sciences, Micro Interventional Devices, Peijia Medical, Tarilian Laser Technologies, Terumo, and Transseptal Solutions.

Market Segmentation & Coverage

This research report categorizes the Aortic Stenosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Valve Type, market is studied across Mechanical Valves and Tissue Valves.
  • Based on Surgery Type, market is studied across Minimally Invasive Surgery and Open Heart Surgery. The Minimally Invasive Surgery is further studied across Robot-Assisted Surgery and Thoracoscopic Surgery. The Open Heart Surgery is further studied across Full Sternotomy and Partial Sternotomy.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Cardiac Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government and private sector initiatives to improve healthcare infrastructure and accessibility
      • 5.1.1.2. Growing investments in research and development for innovative aortic stenosis treatments and devices
      • 5.1.1.3. Favorable reimbursement policies and insurance coverage for aortic stenosis treatments
      • 5.1.1.4. Increasing healthcare expenditure and patient willingness to undergo surgical interventions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging minimally invasive treatments and their potential impact on the aortic stenosis market
      • 5.1.3.2. The role of artificial intelligence in advancing diagnostic precision and treatment outcomes for aortic stenosis
      • 5.1.3.3. Innovative patient engagement strategies to enhance care and compliance in the aortic stenosis segment
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approvals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aortic Stenosis Market, by Valve Type

  • 6.1. Introduction
  • 6.2. Mechanical Valves
  • 6.3. Tissue Valves

7. Aortic Stenosis Market, by Surgery Type

  • 7.1. Introduction
  • 7.2. Minimally Invasive Surgery
    • 7.2.1. Robot-Assisted Surgery
    • 7.2.2. Thoracoscopic Surgery
  • 7.3. Open Heart Surgery
    • 7.3.1. Full Sternotomy
    • 7.3.2. Partial Sternotomy

8. Aortic Stenosis Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Cardiac Centers
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas Aortic Stenosis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Aortic Stenosis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Aortic Stenosis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Balton Sp. z o.o.
  • 3. Biomerics
  • 4. Boston Scientific
  • 5. Bracco Diagnostics
  • 6. Braile Biomedica
  • 7. Cardiovalve
  • 8. Claret Medical
  • 9. CryoLife
  • 10. Edwards Lifesciences
  • 11. JenaValve Technology
  • 12. Johnson & Johnson
  • 13. LivaNova
  • 14. Medtronic
  • 15. Meril Life Sciences
  • 16. Micro Interventional Devices
  • 17. Peijia Medical
  • 18. Tarilian Laser Technologies
  • 19. Terumo
  • 20. Transseptal Solutions

LIST OF FIGURES

  • FIGURE 1. AORTIC STENOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. AORTIC STENOSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AORTIC STENOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AORTIC STENOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AORTIC STENOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. AORTIC STENOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AORTIC STENOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AORTIC STENOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC STENOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AORTIC STENOSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC STENOSIS MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC STENOSIS MARKET SIZE, BY TISSUE VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC STENOSIS MARKET SIZE, BY ROBOT-ASSISTED SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC STENOSIS MARKET SIZE, BY THORACOSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC STENOSIS MARKET SIZE, BY FULL STERNOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC STENOSIS MARKET SIZE, BY PARTIAL STERNOTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AORTIC STENOSIS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AORTIC STENOSIS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AORTIC STENOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. AORTIC STENOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. AORTIC STENOSIS MARKET, FPNV POSITIONING MATRIX, 2023